Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa

Inclusion Criteria:

- Male or female subjects are at least 18 years of age or older

- A confirmed diagnosis of HS disease

- Presence of inflammatory HS lesion(s) and one or more fistula(s) or sinus tracts

Exclusion Criteria:

- Receiving any other kind of treatment for fistulas including introduction of
anti-inflammatory systemic therapy such as prednisone or adalimumab within the prior
month.

- Are participating in another study using an investigational agent or procedure during
participation in this study.

- Have any condition that, in the opinion of the investigator, would compromise the
well-being of the subject or the study.